five

Investigating the Anticancer Activity of Novel 1,2,4-Oxadiazole-Linked 1,2,3-Triazole Moieties via EGFR/pI3K/mTOR Cascade Down-Regulation

收藏
DataCite Commons2025-09-26 更新2025-05-07 收录
下载链接:
https://tandf.figshare.com/articles/dataset/Investigating_the_Anticancer_Activity_of_Novel_1_2_4-Oxadiazole-Linked_1_2_3-Triazole_Moieties_via_EGFR_pI3K_mTOR_Cascade_Down-Regulation/28613648/1
下载链接
链接失效反馈
官方服务:
资源简介:
Malignant transformation, apoptosis prevention, drug resistance, and metastasis are all impacted by the EGFR/PI3K/Akt/mTOR pathway. Usually, mutations in lung and colon cancer alter the expression of this pathway. This led to the creation of a new hybrid of 3,5-diaryl-1,2,4-oxadiazole/1,2,3-triazoles. These hybrids were rationalized and synthesized using click reaction via the Copper catalyzed azide-alkyes cyclo-addition (CuAAC). The antiproliferative properties of the novel library were investigated against lung (A549), colon (Caco-2) cancer cell lines and human lung fibroblast (WI38). <b>5b, 5c, 8a, 8b,</b> and <b>9c</b> showed potent antiproliferative effects (IC<sub>50</sub> 9.18–12.8 µM) against lung (A549). While <b>8a</b> and <b>9a</b> showed substantial cytotoxic effects against the colon (Caco-2) cancer cell line, with IC<sub>50</sub> of 13.0 and 12.0 µM, respectively. It is evident that, in comparison to normal cells, the selective cytotoxic of compound <b>5c</b> (SI 9.4), <b>8a</b> (SI 5.1), and <b>9c</b> (SI 3.7) demonstrated a small selectivity for Caco-2 cells and a significantly higher selectivity for A549 lung cancer cells. Using a CqPCR assay, the powerful cytotoxic compounds <b>5c, 8a</b>, and <b>9c</b> were selected to investigate the mechanism of action of their anticancer activities. It is noteworthy that compounds <b>5c, 8a</b>, and <b>9c</b> were able to inhibit PI3K gene expression by 4.76–8.33 folds, downregulate mTOR by 4.26–4.81 folds, and downstream gene EGFR by 4.55–5.88 times. Additionally, they raised the amount of the p53 gene (a tumor suppressor gene), which bolstered their mode of action. Interestingly, docking experiments of <b>5c, 8a,</b> and <b>9c</b> demonstrated enhanced binding with the important amino acid residues in the EGFR active site (docking energy −7.13, −7.16, and −7.67 kcal/mol, respectively) in comparison to the reference drug gefitinib (−5.84 kcal/mol), which further corroborate their mode of action. The previously mentioned results indicated that the intriguing hits <b>5c, 8a</b>, and <b>9c</b> might be investigated as promising medications.
提供机构:
Taylor & Francis
创建时间:
2025-03-18
二维码
社区交流群
二维码
科研交流群
商业服务